Posted:
12/1/2025, 11:15:18 AM
Location(s):
Sydney, New South Wales, Australia ⋅ New South Wales, Australia
Experience Level(s):
Junior ⋅ Mid Level ⋅ Senior
Field(s):
Medical, Clinical & Veterinary
The Medical Affairs team collaborates with the leaders of Sleep, Respiratory Care, SaaS, ResMed Healthcare, and Asia Growth Markets to ensure our work, especially our clinical research and market access projects, align with their strategic priorities. We also review key government policies, as part of the continuous evaluation and improvement process that helps us maintain global compliance across an ever-shifting landscape of legal and regulatory requirements. The two, research and compliance, work hand-in-hand, and when balanced properly allow us to generate important clinical, economic and market evidence, that improves the lives of patients in ways that are scientifically valid, clinically relevant and ethically sound.
Let’s talk about the team:
As a Clinical Trials Assistant, you will be required to support the Clinical Development Specialists and Medical Affairs Management in the clinical development of new products and assist the planning, development, and implementation of clinical trials across the business. This is an individual contributor role.
*This is a 12 month's contract role*
Let’s talk about the role:
Let’s talk about you:
Required:
Preferred:
Joining us is more than saying “yes” to making the world a healthier place. It’s discovering a career that’s challenging, supportive and inspiring. Where a culture driven by excellence helps you not only meet your goals, but also create new ones. We focus on creating a diverse and inclusive culture, encouraging individual expression in the workplace and thrive on the innovative ideas this generates. If this sounds like the workplace for you, apply now! We commit to respond to every applicant.
Website: https://www.resmed.com/
Headquarter Location: San Diego, California, United States
Employee Count: 10001+
Year Founded: 1989
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Health Care ⋅ Medical ⋅ Medical Device